Allergy · 2023
Telemedicine with special focus on allergic diseases and asthma-Status 2022: An EAACI position paper.
СтатьяПоддержка исследования: вне правительства СШАConsensus StatementНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Smolinska Sylwia, Popescu Florin-Dan, Izquierdo Elena, Antolín-Amérigo Darío, Price Oliver J, Alvarez-Perea Alberto, Eguíluz Gracia Ibon, Papadopoulos Nikolaos G, Pfaar Oliver, Fassio Filippo, Hoffmann-Sommergruber Karin, Dramburg Stephanie, Agache Ioana, Jutel Marek, Brough Helen A, Fonseca João A, Angier Elizabeth, Boccabella Cristina, Bonini Matteo, Dunn Galvin Audrey, Gibson Peter G, Gawlik Radoslaw, Hannachi Farah, Kalayci Ömer, Klimek Ludger, Knibb Rebecca, Matricardi Paolo, Chivato Tomás
Аннотация
Efficacious, effective and efficient communication between healthcare professionals (HCP) and patients is essential to achieve a successful therapeutic alliance. Telemedicine (TM) has been used for decades but during the COVID-19 pandemic its use has become widespread. This position paper aims to describe the terminology and most important forms of TM among HCP and patients and review the existing studies on the uses of TM for asthma and allergy. Besides, the advantages and risks of TM are discussed, concluding that TM application reduces costs and time for both, HCP and patients, but cannot completely replace face-to-face visits for physical examinations and certain tests that are critical in asthma and allergy. From an ethical point of view, it is important to identify those involved in the TM process, ensure confidentiality and use communication channels that fully guarantee the security of the information. Unmet needs and directions for the future regarding implementation, data protection, privacy regulations, methodology and efficacy are described.